ImmunoGen, Inc. (IMGN) Reaches $6.60 After 6.00% Down Move, Ellsworth Fund LTD (ECF) Has 1.23 Sentiment

July 17, 2017 - By Stephen Andrade

The stock of ImmunoGen, Inc. (NASDAQ:IMGN) is a huge mover today! About 1.04 million shares traded. ImmunoGen, Inc. (NASDAQ:IMGN) has declined 3.49% since July 17, 2016 and is downtrending. It has underperformed by 20.19% the S&P500.The move comes after 7 months negative chart setup for the $563.95M company. It was reported on Jul, 17 by We have $6.20 PT which if reached, will make NASDAQ:IMGN worth $33.84M less.

Ellsworth Growth and Income Fund Ltd. operates as a closed-end, diversified management investment company. The company has market cap of $118.72 million. The Fund’s investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. It currently has negative earnings. The Fund invests primarily in convertible and in equity securities, and common stock.

Altfest L J & Co Inc holds 0.39% of its portfolio in Ellsworth Growth and Income Fund Ltd for 93,589 shares. Aviance Capital Partners Llc owns 65,973 shares or 0.19% of their US portfolio. Moreover, Bulldog Investors Llc has 0.16% invested in the company for 77,045 shares. The California-based Concert Wealth Management Inc. has invested 0.16% in the stock. Meridian Investment Counsel Inc., a California-based fund reported 25,157 shares.

It is down 15.85% since July 17, 2016 and is uptrending. It has underperformed by 0.85% the S&P500.

Since January 1, 0001, it had 1 buy, and 0 selling transactions for $5,112 activity.

Among 7 analysts covering Immunogen (NASDAQ:IMGN), 3 have Buy rating, 1 Sell and 3 Hold. Therefore 43% are positive. Immunogen has $24 highest and $500 lowest target. $9.83’s average target is 48.94% above currents $6.6 stock price. Immunogen had 12 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Outperform” rating by RBC Capital Markets given on Thursday, July 6. The company was upgraded on Wednesday, November 25 by Jefferies. The stock of ImmunoGen, Inc. (NASDAQ:IMGN) earned “Outperform” rating by Oppenheimer on Wednesday, July 29. The firm earned “Buy” rating on Monday, June 26 by Jefferies. The rating was maintained by RBC Capital Markets with “Outperform” on Monday, July 27. The firm has “Hold” rating by Cowen & Co given on Sunday, June 4. RBC Capital Markets downgraded ImmunoGen, Inc. (NASDAQ:IMGN) rating on Friday, April 29. RBC Capital Markets has “Sector Perform” rating and $7 target. The firm earned “Market Perform” rating on Wednesday, October 28 by Leerink Swann. The rating was downgraded by Morgan Stanley on Monday, September 21 to “Underweight”. The firm earned “Hold” rating on Tuesday, May 30 by Cantor Fitzgerald.

Investors sentiment increased to 1.14 in 2016 Q4. Its up 0.30, from 0.84 in 2016Q3. It is positive, as 20 investors sold ImmunoGen, Inc. shares while 37 reduced holdings. 21 funds opened positions while 44 raised stakes. 64.19 million shares or 12.81% less from 73.62 million shares in 2016Q3 were reported. Commonwealth Equity Svcs holds 0% or 13,468 shares in its portfolio. Baker Bros Limited Partnership stated it has 0.06% in ImmunoGen, Inc. (NASDAQ:IMGN). Blackrock Institutional Trust Na reported 2.18M shares. Credit Agricole S A invested in 0% or 26,000 shares. Tfs Cap Limited Liability Company has 0.02% invested in ImmunoGen, Inc. (NASDAQ:IMGN) for 28,988 shares. Architects holds 0% or 1,196 shares in its portfolio. Orbimed Advisors Ltd Liability Corp invested in 6.10 million shares or 0.16% of the stock. 93,560 are owned by State Board Of Administration Of Florida Retirement System. Fifth Third Comml Bank holds 6,700 shares or 0% of its portfolio. Ubs Asset Management Americas invested 0% of its portfolio in ImmunoGen, Inc. (NASDAQ:IMGN). Kbc Grp Incorporated Nv owns 281,720 shares. California Public Employees Retirement Sys stated it has 0% in ImmunoGen, Inc. (NASDAQ:IMGN). Walleye Trading Lc holds 82,000 shares. Macquarie Gp Ltd holds 0% or 700,000 shares. D E Shaw & reported 449,256 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: